Raynaud’s Awareness Month focuses on symptoms in extremities

Fact checked byShenaz Bagha

One of the most common manifestations of Raynaud’s syndrome is noticeable in the extremities through numbness, discoloration and pain during the cold weather months, according to the Raynaud’s Association.

As such, the Raynaud’s Association is dedicating the month of October — this year’s Raynaud’s Awareness Month — to bringing awareness to the symptoms that impact the extremities.

Raynauds banner — In honor of Raynaud’s Syndrome awareness month, Healio has compiled five articles dealing with Raynaud’s syndrome.

In recognition of Raynaud’s Awareness Month, Healio has compiled five articles from the past year dealing with Raynaud’s syndrome:

Vasodilators underused for Raynaud’s phenomenon, early systemic sclerosis in veterans

Vasodilator therapy may be underused for Raynaud’s phenomenon and very early systemic sclerosis in U.S. veterans deployed in post-9/11 military operations, according to data published in BMC Rheumatology. Read more.

'Avoid cold and reduce stress' to minimize risk for Raynaud’s phenomenon

Avoiding cold and reducing stress are key to minimizing Raynaud’s phenomenon events, while “good, generic wound care” can be effective in even the most complicated cases. Read more.

Sclerodactyly, Raynaud's, ANA-positivity 'made the diagnosis' for systemic sclerosis

Given the potential for false-positives in Scl-70 antibody testing for systemic sclerosis, many clinicians have overlooked the trio of classic signs and symptoms that would have otherwise “made the diagnosis.” Read more.

Hand function, ulcer prevention top concerns for patients with SSc-related Raynaud’s

Inability to use one’s fingers and the appearance of new ulcers are among the top five concerns that would prompt treatment escalation in patients with Raynaud’s phenomenon secondary to systemic sclerosis, according to data. Read more.

Microvascular complications from CGRP antagonists for migraines uncommon in Raynaud's

Microvascular complications from the use of calcitonin gene-related peptide antagonists for migraines are uncommon in patients with underlying Raynaud’s syndrome, according to data published in JAMA Network Open. Read more.

References:

@Raynaudsorg. https://twitter.com/raynaudsorg/status/1576973171546284035. Oct. 3, 2022. Accessed Oct. 7, 2022.

Published by:

Sources/Disclosures

Collapse

Source:

Healio coverage

Read more

Raynaud’s Awareness Month focuses on symptoms in extremities

References:

Related Content